These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6977595)

  • 1. Evaluation of live and inactivated influenza A virus vaccines in a mouse model.
    Armerding D; Rossiter H; Ghazzouli I; Liehl E
    J Infect Dis; 1982 Mar; 145(3):320-30. PubMed ID: 6977595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.
    Webster RG; Askonas BA
    Eur J Immunol; 1980 May; 10(5):396-401. PubMed ID: 6967815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions.
    Coleclough C; Sealy R; Surman S; Marshall DR; Hurwitz JL
    Scand J Immunol; 2005 Jul; 62 Suppl 1():73-83. PubMed ID: 15953188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes.
    Sambhara S; Woods S; Arpino R; Kurichh A; Tamane A; Underdown B; Klein M; Lövgren Bengtsson K; Morein B; Burt D
    J Infect Dis; 1998 May; 177(5):1266-74. PubMed ID: 9593011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cross protection in mice immunized with different anti-influenza preparations].
    Rudenko LG; Sosunov AV; Zykov MP
    Vopr Virusol; 1981; (6):706-9. PubMed ID: 7336695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of RIT 4025, a live attenuated influenza vaccine strain, and evaluation of heterotypic immunity to influenza A viruses in ferrets.
    Delem A
    J Hyg (Lond); 1977 Oct; 79(2):203-8. PubMed ID: 269196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.
    Jang YH; Kim JY; Byun YH; Son A; Lee JY; Lee YJ; Chang J; Seong BL
    Front Immunol; 2018; 9():116. PubMed ID: 29449842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
    Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to influenza A H9N2 viruses induced by infection and vaccination.
    Lu X; Renshaw M; Tumpey TM; Kelly GD; Hu-Primmer J; Katz JM
    J Virol; 2001 May; 75(10):4896-901. PubMed ID: 11312361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of homotypic and heterotypic T- and B-cell immunity with influenza A virus in mice.
    Armerding D; Liehl E
    Cell Immunol; 1981 May; 60(1):119-35. PubMed ID: 6972261
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
    Schotsaert M; Ysenbaert T; Smet A; Schepens B; Vanderschaeghe D; Stegalkina S; Vogel TU; Callewaert N; Fiers W; Saelens X
    Sci Rep; 2016 Apr; 6():24402. PubMed ID: 27072615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
    Lu X; Edwards LE; Desheva JA; Nguyen DC; Rekstin A; Stephenson I; Szretter K; Cox NJ; Rudenko LG; Klimov A; Katz JM
    Vaccine; 2006 Nov; 24(44-46):6588-93. PubMed ID: 17030078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody production and protection against influenza virus in immunodeficient mice.
    Lucas SJ; Barry DW; Kind P
    Infect Immun; 1978 Apr; 20(1):115-9. PubMed ID: 307534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses.
    Yang JR; Chen CY; Kuo CY; Cheng CY; Lee MS; Cheng MC; Yang YC; Wu CY; Wu HS; Liu MT; Hsiao PW
    Antiviral Res; 2016 Feb; 126():8-17. PubMed ID: 26593980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.